Baganha, F.; Sluiter, T.J.; de Jong, R.C.M.; van Alst, L.A.; Peters, H.A.B.; Jukema, J.W.; Delibegovic, M.; Pettersson, K.; Quax, P.H.A.; de Vries, M.R.
Phosphorylcholine Monoclonal Antibody Therapy Decreases Intraplaque Angiogenesis and Intraplaque Hemorrhage in Murine Vein Grafts. Int. J. Mol. Sci. 2022, 23, 13662.
https://doi.org/10.3390/ijms232113662
AMA Style
Baganha F, Sluiter TJ, de Jong RCM, van Alst LA, Peters HAB, Jukema JW, Delibegovic M, Pettersson K, Quax PHA, de Vries MR.
Phosphorylcholine Monoclonal Antibody Therapy Decreases Intraplaque Angiogenesis and Intraplaque Hemorrhage in Murine Vein Grafts. International Journal of Molecular Sciences. 2022; 23(21):13662.
https://doi.org/10.3390/ijms232113662
Chicago/Turabian Style
Baganha, Fabiana, Thijs J. Sluiter, Rob C. M. de Jong, Louise A. van Alst, Hendrika A. B. Peters, J. Wouter Jukema, Mirela Delibegovic, Knut Pettersson, Paul H. A. Quax, and Margreet R. de Vries.
2022. "Phosphorylcholine Monoclonal Antibody Therapy Decreases Intraplaque Angiogenesis and Intraplaque Hemorrhage in Murine Vein Grafts" International Journal of Molecular Sciences 23, no. 21: 13662.
https://doi.org/10.3390/ijms232113662
APA Style
Baganha, F., Sluiter, T. J., de Jong, R. C. M., van Alst, L. A., Peters, H. A. B., Jukema, J. W., Delibegovic, M., Pettersson, K., Quax, P. H. A., & de Vries, M. R.
(2022). Phosphorylcholine Monoclonal Antibody Therapy Decreases Intraplaque Angiogenesis and Intraplaque Hemorrhage in Murine Vein Grafts. International Journal of Molecular Sciences, 23(21), 13662.
https://doi.org/10.3390/ijms232113662